GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepin...
GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam
About this item
Full title
Author / Creator
Publisher
New Zealand: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Clobazam was initially developed in the early 1970s as a nonsedative anxiolytic agent, and is currently available as adjunctive therapy for epilepsy and anxiety disorders in more than 100 countries. In October 2011, clobazam (Onfi™; Lundbeck Inc., Deerfield, IL, USA) was approved by the US FDA for use as adjunctive therapy for the treatment of seiz...
Alternative Titles
Full title
GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_921569103
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_921569103
Other Identifiers
ISSN
1172-7047
E-ISSN
1179-1934
DOI
10.2165/11599020-000000000-00000
